|
Based on feedback from the July meeting in Guadalajara, the second workshop of the Life Sciences Gateway Initiative will be focused on issues related to inter-institutional partnering and collaboration. The site visits to the various regions revealed that there is potential for achieving critical mass and attracting outside investment through the linking of complementary strengths. However, there is limited experience among the participating organizations in Mexico with creating mutually beneficial partnerships. This workshop will cover both "big picture" and operational details related to developing appropriate platforms that enable collaborative partnerships.
Workshop Agenda
Monday, October 22nd
Location: UCSD Faculty Club, Lounge Room [ map ]
9:00 - 10:30 AM Orientation Session
Introductions and general overview of the workshop.
Why patnering matters and how it can result in mutual benefits.
10:30 AM - 12:30 PM Institution-to-Institution Parntering
Univerity-to-university and university-hospital parnterships will be described. Specific issues include developing a legal framework, sharing intellectual property (IP), sharing resources, financing the partnership, and benefits and challenges associated with partnering.
- Gabriel Haddad, M.D., Chairman, Department of Pediatrics, UC San Diego School of Medicine
- Meg Norton, Senior Vice President, Rady Children's Hospital
- John Wooley, Ph.D., Professor, Department of Pharmacology, UC San Diego; Co-PI, Joint Center for Structural Genomics (a parntership of UC San Diego, Genomics Institute of the Novartis Foundation, The Scripps Research Institute, the Burnham Institute for Medical Research, and the Stanford Synchrotron Radiation Laboratory)
1:00 - 2:30 PM Lunch
Keynote speaker: Constanza Pachon, Chief of Staff & Director of Operations, Larta Institute
Larta's NETWORK T2 is a consortium of 19 universities and non-profit research institutions, along with private sector industry affiliates, designed to facilitate a more efficient process of technology commericialization. NETWORK T2 represents a platform that links these organizations together. Ms. Pachon will describe how such a large partnership was assembled.
2:30 - 4:30 PM Working with Contract Research Organizations (CROs)
CROs are imporant players in the clinical trials process. This panel will discuss issues related to working with a CRO from the perspectives of the university, hospitals, and CROs themselves.
- Mike Ziegler, M.D., Director, General Clinical Research Center, UC San Diego
- Kal Chatto, Co-Founder, Manipal Acunova
- Neil Singla, M.D., Director of Clinical Research, Huntington Memorial Hospital; President, Clinical Management Services, Inc.
5:30 - 7:00 PM Reception
Off-site reception hosted by Luce Forward Hamilton & Scripps LLP at their San Diego office. Luce forward provides comprehensive legal counsel to a broad spectrum of businesses, including many start-up ventures, closely held firms, publicly traded companies and multinational corporations headquartered in Southern California, across the United States, and in Canada, Mexico and the rest of Latin America, Asia and Europe.
Tuesday, October 23rd
Location: UCSD Faculty Club, Lounge Room [ map ]
9:00 - 10:30 AM Partnering with Industry
This session will cover how universities and hospitals work with the private sector in life science research partnerships through mechanisms such as joint research projects, corporate affiliate programs, and others. Issues of how these partnerships are developed, structured, and maintained will be covered.
11:00 AM - 12:30 PM Site Visit
Visit to the Rebecca and John Moores UCSD Cancer Center to learn about the new facility, and the Center's patient treatment and clinical research capabilities. The Center currently accommodates 40,000 outpatient visits per year. The Center is also conducting more than 150 clinical trials at any given time. The Cancer Center represents a key asset for translational research in the region.
1:00 - 2:00 PM Lunch and Overview of Action Plan Development
An overview and instructions for the afternoon's working groups will be provided. The working groups will be tasked with developing draft partering action plans and timelines. Pending availability and confirmation, outside experts will be brought in to assist the working groups.
2:00 - 5:00 PM Parntering Action Plan and Timeline Development
Participants will break in to 3-4 small working groups to develop a concept action plan for partering. Each action plan will include an overall goal, key stakeholders who will be needed, at least three action items to develop the partnership, and a basic timeline for implementation. The suggested working groups are:
- Creating a site management organization (SMO) or contract research orgnazation (CRO) to support clinical research
- Technology-based services (e.g. creating a National Reagent Consortium or an Industrial Microbiology Consortium)
- Science-based opportunities (e.g. nutraceuticals, developing a shared infrastructure for applied research, etc.)
- Planning for the panel Merck is supporting at the BIO 2008 conference in San Diego
During the last hour participants will present their plans in a plenary session to receive feedback from the larger group. Lastly, the working groups will be asked to provide a progress report on implementing their plans at the next workshop (~January 2008).
5:30 - 7:30 PM Workshop Closing Dinner
Background Information on San Diego's Life Sciences Industry
America's Biotech and Life Sciences Clusters: San Diego's Position and Economic Contributions
The Milken Institute, June 2004
BIOCOM, San Diego's life sciences industry trade association
California Institute for Regenerative Medicine - San Diego Presentation to the Independent Citizens Oversight Committee (ICOC) [ pdf 1.43MB ], May 6, 2005
Clusters of Innovation Initiative: San Diego [ pdf 195.5KB ], 2001
Michael Porter cluster analysis of San Diego, sponsored by the Council on Competitiveness
CONNECT-dex [ pdf 1.2MB ], April 2007
The first comprehensive measure of high technology company creation in San Diego County. Conducted by CONNECT.
|
